Therefore, our study found a novel feedback loop involving the SRSF1/circATP5B/miR-185-5p/HOXB5 axis that regulates the proliferation of GSCs and may provide a novel target for glioma therapy. The gene discussed is SRSF1; the disease is central nervous system cancer.